MSH2 and cancer: The overall aim of this prospective, multicentre, randomised study was to evaluate whether healthcare-assisted disclosure increases GC uptake in ARRs compared to family-mediated disclosure alone, focusing on high-risk cancer predisposition genes (BRCA1, BRCA2, PALB2, MLH1, MSH2, MSH6, PMS2).